Sercan ÖN
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Research areas: Health Sciences, Medicine, Urology, Surgery Medicine Sciences, Internal Medicine Sciences, Internal Diseases, Obstetrics and Gynecology, Oncology
Publications
- Jinekolojik Kanserlerde İmmünoterapi (2026)
- Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (2026)
- Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG) (2026)
- Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis (2026)
- Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC (2026)
- Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG) (2026)
- DUSP29 does not regulate melanoma–myoblast interactions in a skeletal muscle co-culture model (2026)
- Feasibility and Safety of Rapid Drug Desensitization for Chemotherapy-Induced Maculopapular Eruptions (2026)
- Turkish Cross-Cultural Adaptation of the BRIEF-MPI in Older Adults with Cancer: Convergent and Discriminative Validity Compared with the G8 and Clinical Frailty Scale (2026)
- Treatment Outcomes and Toxicity of Cisplatin–Etoposide-Based Regimens and Carboplatin–Paclitaxel as Adjuvant Chemotherapy for Ovarian Adult Granulosa Cell Tumors: A Multicenter Retrospective Cohort Study (2026)
- Comment of ‘Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries’ (2026)
- Level of Knowledge and Awareness of Newly Diagnosed Cancer Patients About Cancer Diagnosis (2025)
- Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index (2025)
- Efficacy of pembrolizumab in patients with chemotherapy-resistant gestational trophoblastic neoplasia, a case report (2025)
- Body Mass Index as an Independent Prognostic Factor in Second-Line Nivolumab Therapy for Metastatic Clear Cell Renal Cell Carcinoma (2025)
- Long-term Outcomes in Stage I Seminoma Patients: A Single-center Retrospective Study (2025)
- Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group (2025)
- Gastroenteropancreatic Neuroendocrine Tumors: Epidemiologic and Clinical Features (2025)
- Beyin Metastazı Gelişen Solid Tümörlü Hastaların Özellikleri ve Sağ Kalımın Değerlendirilmesi (2025)
- Real-World Outcomes Of HER2-Positive Metastatic Gastric Cancer Patients Treated With Trastuzumab-Based Therapy: A Single-Center Experience (2025)
- ATM Heterozygous Variant Identified in a Breast Cancer Case series (2025)
- 406P Risk of second primary cancer in a ten-year follow-up period among turkish breast cancer survivors: Results from the turkish oncology group cohort (2025)
- Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG) (2024)
- Radiotherapy can be a Cofactor in the Development and Severity of Lapatinib-Capecitabine-Related Skin Rash (2024)
- Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study (2024)
- Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib (2024)
- Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: A retrospective multi-center study by the Turkish Oncology Group (TOG). (2024)
- Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group (2023)
- PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study (2023)
- Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye (2023)
- Radiotherapy can be a Cofactor in the Development and Severity of Lapatinib-Capecitabine-Related Skin Rash (2023)
- Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program-LynTurk study (2023)
- 230P Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study (2023)
- Yaşlı Kanser Hastalarında İmmunoterapi (2022)
- Immunotherapy-induced granulomatous reaction in patients with melanoma (2022)
- Evaluation of Treatment Efficacy of Tyrosine Kinase inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience (2022)
- Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group (2022)
- Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study (2022)
- Geriatrik (≥65 Yaş) Meme Kanseri Hastalarında CDK 4/6 İnhibitörlerine Bağlı Toksisiteler Ve Yönetimi, Bir Prospektif Tog Çalışması (2022)
- Neoadjuvant Chemotherapy Data in Signet Ring Cell Gastric Carcinoma (2022)
- Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience (2022)
- MESANE KANSERİNDE GERİATRİK HASTA YÖNETİMİ (2021)
- Kanser İmmunoterapisi, Monoklonal Antikor ve Tirozin Kinaz İnhibitörü Alan Hastalarda Geç Tip Aşırı Duyarlılık Reaksiyonlarının İnsidans ve Tip Belirleme Çalışması (2021)
- COVID-19 SALGINI NEDENİ İLE AĞIR İLAÇ ALLERJİLERİNİN BAŞARILI DESENSİTİZASYONLARI TAKİBEN ''TREATİNG THROUGH'' KONSEPTİ GÖZETİLEREK YÖNETİLMESİ (2021)
- Neoadjuvan tedavide Pertuzumab alan meme kanseri hastalarının genel özellikleri (2021)
- Denovo metastatik pankreas kanserinde FOLFİRİNOX tedavisi sırasında gelişen hipoalbumineminin sağkalım üzerine etkisinin değerlendirilmesi (2021)
- ONKOLOJİK HASTADA PREOPERATİF DEĞERLENDİRME (2020)
- PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY) (2020)